Clinical Trial Update: POTS Adrenergic Ab (CIHR Aims #1&2)

View source ↗

Summary

Clinical trial update indicating recruitment for a study investigating a POTS adrenergic antibody.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Tachycardia Syndrome

Drugs mentioned

• POTS Adrenergic Ab (Adrenergic antibody)

Snippet

Sponsor: University of Calgary | Conditions: Postural Tachycardia Syndrome | Status: RECRUITING